To determine the detection sensitivity and specificity of the two methods in BRAF V600E detection, nine papillary thyroid cancer specimens were included in the study and their BRAF V600E mutation statuses were determined using Sanger sequencing, developed RT-qPCR and V600E-specific immunohistochemistry. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.